Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
The progress and promise of molecular imaging probes in oncologic drug developmentGary J Kelloff, Kenneth A Krohn, Steven M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted 18F-Fluorthanatrace PET in Breast CancerAnthony J Young, Austin R Pantel, Mahsa Kiani, et al.
The Journal of Clinical Investigation|September 15, 2022
Imaging sensitive and drug-resistant bacterial infection with [11C]-trimethoprimIris K Lee, Daniel A Jacome, Joshua K Cho, et al.
Journal of the American College of Radiology : JACR|November 6, 2016
ACR Appropriateness Criteria® Stage I Breast CarcinomaPhan Tuong Huynh, Sergy V Lemeshko, Mary C Mahoney, et al.
Journal of the American College of Radiology : JACR|July 4, 2012
ACR Appropriateness Criteria® stage I breast carcinomaPhan Tuong Huynh, Sergy V Lemeshko, Mary C Mahoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2016
Quantitative Imaging in Cancer Clinical TrialsThomas E Yankeelov, David A Mankoff, Lawrence H Schwartz, et al.
Journal of the American College of Radiology : JACR|January 8, 2013
ACR Appropriateness Criteria Breast Cancer ScreeningMartha B Mainiero, Ana Lourenco, Mary C Mahoney, et al.
Journal of the American College of Radiology : JACR|November 6, 2016
ACR Appropriateness Criteria Breast Cancer ScreeningMartha B Mainiero, Ana Lourenco, Mary C Mahoney, et al.
Leukemia & Lymphoma|November 12, 2025
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141)Robert Jeraj, Fenghai Duan, Ryan J Mattison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2022
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot StudyAustin R Pantel, Sarah B Gitto, Mehran Makvandi, et al.
Pageof 23